Foulkes WD - Search Results

1

Data sharing to improve concordance in variant interpretation across laboratories: results from the Canadian Open Genetics Repository.

Mighton C, Smith AC, Mayers J, Tomaszewski R, Taylor S, Hume S, Agatep R, Spriggs E, Feilotter HE, Semenuk L, Wong H, Lazo de la Vega L, Marshall CR, Axford MM, Silver T, Charames GS, Di Gioacchino V, Watkins N, Foulkes WD, Clavier M, Hamel N, Chong G, Lamont RE, Parboosingh J, Karsan A, Bosdet I, Young SS, Tucker T, Akbari MR, Speevak MD, Vaags AK, Lebo MS, Lerner-Ellis J; Canadian Open Genetics Repository Working Group. Mighton C, et al. Among authors: foulkes wd. J Med Genet. 2022 Jun;59(6):571-578. doi: 10.1136/jmedgenet-2021-107738. Epub 2021 Apr 19. J Med Genet. 2022. PMID: 33875564 Free PMC article.

2

Genetic screening for breast cancer.

Rosenblatt DS, Foulkes WD, Narod SA. Rosenblatt DS, et al. Among authors: foulkes wd. N Engl J Med. 1996 May 2;334(18):1200-1. doi: 10.1056/NEJM199605023341815. N Engl J Med. 1996. PMID: 8602200 No abstract available.

3

Increased incidence of cancer in first degree relatives of women with double primary carcinomas of the breast and colon.

Foulkes WD, Bolduc N, Lambert D, Ginsburg O, Olien L, Yandell DW, Tonin PN, Narod SA. Foulkes WD, et al. J Med Genet. 1996 Jul;33(7):534-9. doi: 10.1136/jmg.33.7.534. J Med Genet. 1996. PMID: 8818936 Free PMC article.

4

Pancreatic adenocarcinoma: epidemiology and genetics.

Flanders TY, Foulkes WD. Flanders TY, et al. Among authors: foulkes wd. J Med Genet. 1996 Nov;33(11):889-98. doi: 10.1136/jmg.33.11.889. J Med Genet. 1996. PMID: 8950667 Free PMC article. Review.

5

Is hereditary site-specific ovarian cancer a distinct genetic condition?

Liede A, Tonin PN, Sun CC, Serruya C, Daly MB, Narod SA, Foulkes WD. Liede A, et al. Among authors: foulkes wd. Am J Med Genet. 1998 Jan 6;75(1):55-8. doi: 10.1002/(sici)1096-8628(19980106)75:1<55::aid-ajmg12>3.0.co;2-r. Am J Med Genet. 1998. PMID: 9450858

6

No association between P53 codon 72 polymorphism and risk of squamous cell carcinoma of the head and neck.

Hamel N, Black MJ, Ghadirian P, Foulkes WD. Hamel N, et al. Among authors: foulkes wd. Br J Cancer. 2000 Feb;82(4):757-9. doi: 10.1054/bjoc.1999.0993. Br J Cancer. 2000. PMID: 10732740 Free PMC article.

7

A rapid fluorescent multiplexed-PCR analysis (FMPA) for founder mutations in the BRCA1 and BRCA2 genes.

Kuperstein G, Foulkes WD, Ghadirian P, Hakimi J, Narod SA. Kuperstein G, et al. Among authors: foulkes wd. Clin Genet. 2000 Mar;57(3):213-20. doi: 10.1034/j.1399-0004.2000.570307.x. Clin Genet. 2000. PMID: 10782928

8

Role of molecular diagnostic testing in familial adenomatous polyposis and hereditary nonpolyposis colorectal cancer families.

Rabelo R, Foulkes W, Gordon PH, Wong N, Yuan ZQ, MacNamara E, Chong G, Pinsky L, Lasko D. Rabelo R, et al. Dis Colon Rectum. 2001 Mar;44(3):437-46. doi: 10.1007/BF02234746. Dis Colon Rectum. 2001. PMID: 11289293 Review.

9

Prevalence of founder BRCA1 and BRCA2 mutations in unselected French Canadian women with breast cancer.

Chappuis PO, Hamel N, Paradis AJ, Deschênes J, Robidoux A, Potvin C, Cantin J, Tonin P, Ghadirian P, Foulkes WD. Chappuis PO, et al. Among authors: foulkes wd. Clin Genet. 2001 Jun;59(6):418-23. doi: 10.1034/j.1399-0004.2001.590606.x. Clin Genet. 2001. PMID: 11453973

10

Multimodal molecular screening is required to improve the sensitivity of MLH1 and MSH2 mutation analysis.

Andermann A, Thiffault I, Wong N, Gordon P, MacNamara E, Chong G, Foulkes W. Andermann A, et al. J Clin Oncol. 2002 Mar 15;20(6):1705-7. doi: 10.1200/JCO.2002.20.6.1705. J Clin Oncol. 2002. PMID: 11896123 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

738 results

Search Page